These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27180415)

  • 21. Acceptability of hepatitis C virus testing methods among injecting drug users.
    White B; Day C; Thein HH; Doab A; Bates A; Holden J; van Beek I; Maher L
    Drug Alcohol Rev; 2008 Nov; 27(6):666-70. PubMed ID: 19378449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
    Khaw FM; Stobbart L; Murtagh MJ
    BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights in Public Health: Reframing Hepatitis C: Lessons in Successful Public Health Collaboration.
    Pham T; Wasserman GM
    Hawaii J Med Public Health; 2017 Dec; 76(12):346-349. PubMed ID: 29242761
    [No Abstract]   [Full Text] [Related]  

  • 24. Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti.
    Hepburn MJ; Lawitz EJ
    BMC Gastroenterol; 2004 Dec; 4():31. PubMed ID: 15596018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hepatitis C virus really have no effect on survival in cases of infection with human immunodeficiency virus?
    Jenny-Avital ER
    Clin Infect Dis; 2000 Feb; 30(2):409-10. PubMed ID: 10671362
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.
    Pontali E; Ferrari F
    Int J Prison Health; 2008; 4(2):77-82. PubMed ID: 18464061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C--a threat to public health.
    J Ark Med Soc; 1997 Jul; 94(2):82. PubMed ID: 9231618
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
    Bowden S; McCaw R; White PA; Crofts N; Aitken CK
    J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of hepatitis C virus in syringes confiscated in prisons in Australia.
    Dolan K; Larney S; Jacka B; Rawlinson W
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.
    Baćak V; Laušević D; Mugoša B; Vratnica Z; Terzić N
    Eur Addict Res; 2013; 19(2):68-73. PubMed ID: 23006531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C: new CDC screening recommendations.
    Campos-Outcalt D
    J Fam Pract; 2012 Dec; 61(12):744-6. PubMed ID: 23313992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug addiction and hepatitis C: does a correlation exist between the laboratory and clinical pictures?].
    Marioni CF; Rapisarda L; Butelli S
    Recenti Prog Med; 1992 Dec; 83(12):690-1. PubMed ID: 1337387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening blood-borne virus among incarcerated inmates.
    Chong VH
    Int J STD AIDS; 2008 Nov; 19(11):795. PubMed ID: 18931282
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of HCV incidence in drug users in France.
    Lucidarme D; Duburque C; Bulois P; Filoche B
    Epidemiol Infect; 2011 Sep; 139(9):1287-95. PubMed ID: 21418713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [General practice patterns in hepatitis C virus mass screening in the Lyons region].
    Sahajian F; Caillat-Vallet E; Bailly F; Excler G; Trepo C; Fabry J; Sepetjan M
    Sante Publique; 1999 Dec; 11(4):513-25. PubMed ID: 10798177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of a hepatitis C screening programme for US veterans.
    Zuniga IA; Chen JJ; Lane DS; Allmer J; Jimenez-Lucho VE
    Epidemiol Infect; 2006 Apr; 134(2):249-57. PubMed ID: 16490127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C screening in genitourinary clinic attendees.
    Kerr RS; Fernando I; Templeton K; Flynn B
    Int J STD AIDS; 2009 Nov; 20(11):808. PubMed ID: 19854881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.